"Bij ons in Amphia draait het om mensen en hun gezondheid. Iedereen heeft recht op de beste zorg én goede service en aandacht. Dit geldt voor onze patiënten, bezoekers en mantelzorgers. Maar ook voor onze eigen (zorg)medewerkers. Elke dag staan ruim 340 medisch specialisten, 4300 medewerkers en 340 vrijwilligers klaar om samen met de patiënt te werken aan haar of zijn gezondheid. Amphia is lid van de Vereniging van Samenwerkende Topklinische opleidingsZiekenhuizen (STZ). Lid zijn van STZ betekent dat wij opleiding, onderwijs en onderzoek heel belangrijk vinden. Wij willen altijd in ontwikkeling zijn. Hier richten we dus veel aandacht op. Amphia biedt veel opleidingsmogelijkheden voor artsen, verpleegkundigen en paramedici."

During the past decade, Amphia Ziekenhuis, locatie Langendijk conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Amphia Ziekenhuis, locatie Langendijk" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Bayer" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Amphia Ziekenhuis, locatie Langendijk" #1 collaborator was "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Amphia Ziekenhuis, locatie Langendijk" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Lymphoma" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Amphia Ziekenhuis, locatie Langendijk" in a lesser frequency.

Most popular intervention types in "Amphia Ziekenhuis, locatie Langendijk" are "Drug" (18 trials), "Biological" (5 trials), "Device" (2 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "prednisone" (3 trials), "Apixaban" (2 trials), "Apixaban matching placebo" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Amphia Ziekenhuis, locatie Langendijk" are 22 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Amphia Ziekenhuis, locatie Langendijk". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Amphia Ziekenhuis, locatie Langendijk, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Amphia Ziekenhuis, locatie Langendijk, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".